Actos /Usa/ (Pioglitazone Hydrochloride)



Combined with:

Indications and Reactions:

Role Indications Reactions
Concomitant
Type 2 Diabetes Mellitus 87.9%
Insulin-requiring Type 2 Diabetes Mellitus 5.5%
Diabetes Mellitus 1.9%
Insulin-requiring Type Ii Diabetes Mellitus 1.1%
Type 1 Diabetes Mellitus 0.6%
Weight Control 0.5%
Weight Decreased 0.5%
Back Pain 0.3%
Blood Glucose Increased 0.3%
Glucose Tolerance Impaired 0.3%
Depression 0.2%
Diabetic Neuropathy 0.2%
Insulin Resistant Diabetes 0.2%
Obesity 0.2%
Scan Myocardial Perfusion 0.2%
Weight Increased 0.2%
Weight Decreased 31.8%
Blood Glucose Increased 17.5%
Nausea 12.9%
Vomiting 6.8%
Weight Increased 6.4%
Tremor 5.7%
Incorrect Dose Administered 4.3%
Drug Effect Decreased 2.7%
Drug Ineffective 2.1%
Injection Site Pain 2.1%
Glycosylated Haemoglobin Increased 1.0%
Hyperhidrosis 1.0%
Injection Site Irritation 1.0%
Injection Site Extravasation 0.8%
Injection Site Haemorrhage 0.8%
Diarrhoea 0.6%
Drug Prescribing Error 0.6%
Fatigue 0.6%
Feeling Jittery 0.6%
Headache 0.6%